| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Design and validation of a histological scoring system for nonalcoholic fatty liver disease.
|
Hepatology
|
2005
|
29.57
|
|
2
|
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.
|
N Engl J Med
|
2010
|
13.33
|
|
3
|
The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.
|
Hepatology
|
2012
|
11.03
|
|
4
|
A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells.
|
Nature
|
2008
|
10.84
|
|
5
|
The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology.
|
Gastroenterology
|
2012
|
5.47
|
|
6
|
AAV vector integration sites in mouse hepatocellular carcinoma.
|
Science
|
2007
|
3.73
|
|
7
|
Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial.
|
JAMA
|
2011
|
3.37
|
|
8
|
Nonalcoholic fatty liver disease: pathology and pathogenesis.
|
Annu Rev Pathol
|
2010
|
3.36
|
|
9
|
Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone.
|
Hepatology
|
2003
|
3.23
|
|
10
|
Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction.
|
Gastroenterology
|
2007
|
3.18
|
|
11
|
Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers.
|
Hepatology
|
2004
|
3.00
|
|
12
|
Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace.
|
J Hepatol
|
2012
|
2.89
|
|
13
|
Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial.
|
Hepatology
|
2009
|
2.88
|
|
14
|
Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease.
|
Hepatology
|
2010
|
2.86
|
|
15
|
Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent.
|
Am J Physiol Gastrointest Liver Physiol
|
2008
|
2.45
|
|
16
|
Endpoints and clinical trial design for nonalcoholic steatohepatitis.
|
Hepatology
|
2011
|
2.44
|
|
17
|
The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury.
|
Hepatology
|
2011
|
2.42
|
|
18
|
Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease.
|
Am J Gastroenterol
|
2011
|
2.15
|
|
19
|
Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow-up of 150 patients.
|
Hepatology
|
2009
|
2.07
|
|
20
|
Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease.
|
Hepatology
|
2010
|
1.98
|
|
21
|
Microscopic margins and patterns of treatment failure in resected pancreatic adenocarcinoma.
|
Arch Surg
|
2012
|
1.91
|
|
22
|
Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice.
|
Am J Physiol Gastrointest Liver Physiol
|
2012
|
1.83
|
|
23
|
Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis.
|
Radiology
|
2013
|
1.77
|
|
24
|
Pathology of nonalcoholic fatty liver disease.
|
Am J Clin Pathol
|
2007
|
1.76
|
|
25
|
Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD).
|
J Hepatol
|
2012
|
1.70
|
|
26
|
Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease.
|
Hepatology
|
2002
|
1.68
|
|
27
|
Ballooned hepatocytes in steatohepatitis: the value of keratin immunohistochemistry for diagnosis.
|
J Hepatol
|
2008
|
1.68
|
|
28
|
Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research.
|
Semin Liver Dis
|
2012
|
1.68
|
|
29
|
Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease.
|
J Hepatol
|
2008
|
1.67
|
|
30
|
Ketogenesis prevents diet-induced fatty liver injury and hyperglycemia.
|
J Clin Invest
|
2014
|
1.63
|
|
31
|
The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.
|
Am J Gastroenterol
|
2012
|
1.61
|
|
32
|
Duration of hepatic iron exposure increases the risk of significant fibrosis in hereditary hemochromatosis: a new role for magnetic resonance imaging.
|
Am J Gastroenterol
|
2005
|
1.54
|
|
33
|
Comparison of liver biopsy and noninvasive methods for diagnosis of hepatocellular carcinoma.
|
Clin Gastroenterol Hepatol
|
2006
|
1.49
|
|
34
|
Hepatic iron overload in blacks and whites: a comparative autopsy study.
|
Am J Gastroenterol
|
2003
|
1.49
|
|
35
|
What's in a NAme?
|
Hepatology
|
2009
|
1.49
|
|
36
|
Treatment of nonalcoholic fatty liver disease in children: TONIC trial design.
|
Contemp Clin Trials
|
2009
|
1.48
|
|
37
|
Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis?
|
Arch Pathol Lab Med
|
2008
|
1.42
|
|
38
|
Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study.
|
Hepatology
|
2009
|
1.37
|
|
39
|
Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects.
|
Gastroenterology
|
2012
|
1.27
|
|
40
|
Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network.
|
Hepatology
|
2009
|
1.26
|
|
41
|
Overexpression of OATP1B3 confers apoptotic resistance in colon cancer.
|
Cancer Res
|
2008
|
1.20
|
|
42
|
Evolution of hepatitis C viral quasispecies after liver transplantation.
|
Gastroenterology
|
2002
|
1.18
|
|
43
|
Gender dimorphic formation of mouse Mallory-Denk bodies and the role of xenobiotic metabolism and oxidative stress.
|
Gastroenterology
|
2010
|
1.14
|
|
44
|
Hepatic steatosis, inflammation, and ER stress in mice maintained long term on a very low-carbohydrate ketogenic diet.
|
Am J Physiol Gastrointest Liver Physiol
|
2011
|
1.13
|
|
45
|
Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial.
|
Hepatology
|
2010
|
1.12
|
|
46
|
Dynamic and differential regulation of proteins that coat lipid droplets in fatty liver dystrophic mice.
|
J Lipid Res
|
2009
|
1.12
|
|
47
|
Pentoxifylline for the treatment of non-alcoholic steatohepatitis: a randomized controlled trial.
|
Ann Hepatol
|
2011
|
1.11
|
|
48
|
Circulating mesothelin protein and cellular antimesothelin immunity in patients with pancreatic cancer.
|
Clin Cancer Res
|
2009
|
1.08
|
|
49
|
Fibrosis progression in chronic hepatitis C: morphometric image analysis in the HALT-C trial.
|
Hepatology
|
2009
|
1.08
|
|
50
|
Jaundice: an important, poorly recognized risk factor for diminished survival in patients with adenocarcinoma of the head of the pancreas.
|
HPB (Oxford)
|
2013
|
1.08
|
|
51
|
The genetic background modulates susceptibility to mouse liver Mallory-Denk body formation and liver injury.
|
Hepatology
|
2008
|
1.07
|
|
52
|
Keratin mutation predisposes to mouse liver fibrosis and unmasks differential effects of the carbon tetrachloride and thioacetamide models.
|
Gastroenterology
|
2008
|
1.07
|
|
53
|
Biliary-venous fistula complicating transjugular intrahepatic portosystemic shunt presenting with recurrent bacteremia, jaundice, anemia and fever.
|
Am J Transplant
|
2003
|
1.04
|
|
54
|
Diabetic hepatosclerosis: diabetic microangiopathy of the liver.
|
Arch Pathol Lab Med
|
2006
|
1.02
|
|
55
|
Endoplasmic reticulum stress is a mediator of posttransplant injury in severely steatotic liver allografts.
|
Liver Transpl
|
2011
|
1.00
|
|
56
|
Effect of significant histologic steatosis or steatohepatitis on response to antiviral therapy in patients with chronic hepatitis C.
|
Clin Gastroenterol Hepatol
|
2005
|
0.97
|
|
57
|
Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis.
|
Liver Int
|
2013
|
0.97
|
|
58
|
Diabetic hepatosclerosis: a 10-year autopsy series.
|
Liver Int
|
2009
|
0.97
|
|
59
|
Polypoid lesions of the gallbladder: disease spectrum with pathologic correlation.
|
Radiographics
|
2015
|
0.94
|
|
60
|
Hepatic expression of cell death-inducing DFFA-like effector C in obese subjects is reduced by marked weight loss.
|
Obesity (Silver Spring)
|
2009
|
0.94
|
|
61
|
SALL4 immunoreactivity predicts prognosis in Western hepatocellular carcinoma patients but is a rare event: a study of 236 cases.
|
Am J Surg Pathol
|
2014
|
0.94
|
|
62
|
Interim results of a pilot study demonstrating the early effects of the PPAR-gamma ligand rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitis.
|
J Hepatol
|
2003
|
0.94
|
|
63
|
Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease.
|
J Hepatol
|
2010
|
0.93
|
|
64
|
Rapamycin reduces intrahepatic alpha-1-antitrypsin mutant Z protein polymers and liver injury in a mouse model.
|
Exp Biol Med (Maywood)
|
2010
|
0.93
|
|
65
|
Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations.
|
Hepatology
|
2012
|
0.93
|
|
66
|
Bone marrow biopsy in patients with hepatitis C virus infection: spectrum of findings and diagnostic utility.
|
Am J Hematol
|
2010
|
0.92
|
|
67
|
Misuse of scoring systems.
|
Hepatology
|
2011
|
0.91
|
|
68
|
Liver fatty acid binding protein (L-Fabp) modulates murine stellate cell activation and diet-induced nonalcoholic fatty liver disease.
|
Hepatology
|
2013
|
0.91
|
|
69
|
Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: a pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up study.
|
Hepatology
|
2012
|
0.91
|
|
70
|
Characteristics of hepatocellular carcinoma in a murine model of alpha-1-antitrypsin deficiency.
|
Hepatol Res
|
2010
|
0.91
|
|
71
|
American Association for the Study of Liver Diseases endpoints conference: design and endpoints for clinical trials in primary biliary cirrhosis.
|
Hepatology
|
2010
|
0.91
|
|
72
|
Expression of HSP47, a collagen-specific chaperone, in normal and diseased human liver.
|
Lab Invest
|
2005
|
0.90
|
|
73
|
Mallory-Denk bodies are associated with outcomes and histologic features in patients with chronic hepatitis C.
|
Clin Gastroenterol Hepatol
|
2011
|
0.90
|
|
74
|
Costaining for keratins 8/18 plus ubiquitin improves detection of hepatocyte injury in nonalcoholic fatty liver disease.
|
Hum Pathol
|
2011
|
0.89
|
|
75
|
Relations of steatosis type, grade, and zonality to histological features in pediatric nonalcoholic fatty liver disease.
|
J Pediatr Gastroenterol Nutr
|
2011
|
0.89
|
|
76
|
CD36 deletion reduces VLDL secretion, modulates liver prostaglandins, and exacerbates hepatic steatosis in ob/ob mice.
|
J Lipid Res
|
2013
|
0.89
|
|
77
|
Epstein-Barr virus hepatitis: diagnostic value of in situ hybridization, polymerase chain reaction, and immunohistochemistry on liver biopsy from immunocompetent patients.
|
Am J Surg Pathol
|
2007
|
0.88
|
|
78
|
Accelerated hepatic fibrosis in patients with combined hereditary hemochromatosis and chronic hepatitis C infection.
|
J Hepatol
|
2002
|
0.88
|
|
79
|
Nonalcoholic fatty liver disease.
|
Clin Liver Dis
|
2010
|
0.86
|
|
80
|
Budd-Chiari syndrome and hepatocellular carcinoma: a case report and review of the literature.
|
Am J Gastroenterol
|
2003
|
0.86
|
|
81
|
Dietary trans-fatty acid induced NASH is normalized following loss of trans-fatty acids from hepatic lipid pools.
|
Lipids
|
2012
|
0.86
|
|
82
|
Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma.
|
Abdom Imaging
|
2014
|
0.85
|
|
83
|
Hepatocellular carcinoma: predisposing conditions and precursor lesions.
|
Gastroenterol Clin North Am
|
2002
|
0.85
|
|
84
|
Hepatic iron concentration does not influence response to therapy with interferon plus ribavirin in chronic HCV infection.
|
J Interferon Cytokine Res
|
2002
|
0.85
|
|
85
|
Short- and long-term outcomes after steatotic liver transplantation.
|
Arch Surg
|
2010
|
0.85
|
|
86
|
Hepatic steatosis in human immunodeficiency virus: a prospective study in patients without viral hepatitis, diabetes, or alcohol abuse.
|
J Clin Gastroenterol
|
2013
|
0.85
|
|
87
|
Keratin 19 epithelial patterns in cirrhotic stroma parallel hepatocarcinogenesis.
|
Am J Pathol
|
2011
|
0.84
|
|
88
|
Orlistat in the treatment of NASH: a case series.
|
Am J Gastroenterol
|
2003
|
0.84
|
|
89
|
Fighting the bushfire in HCC trials.
|
J Hepatol
|
2011
|
0.84
|
|
90
|
Differential findings for CD14-positive hepatic monocytes/macrophages in primary biliary cirrhosis, chronic hepatitis C and nonalcoholic steatohepatitis.
|
Liver Int
|
2006
|
0.83
|
|
91
|
CD14-positive hepatic monocytes/macrophages increase in hereditary hemochromatosis.
|
Liver Int
|
2004
|
0.83
|
|
92
|
The effects of 48 weeks of rosiglitazone on hepatocyte mitochondria in human nonalcoholic steatohepatitis.
|
Hepatology
|
2007
|
0.82
|
|
93
|
Effect of iron overload and dietary fat on indices of oxidative stress and hepatic fibrogenesis in rats.
|
Liver Int
|
2003
|
0.82
|
|
94
|
Multi-SNP analysis of GWAS data identifies pathways associated with nonalcoholic fatty liver disease.
|
PLoS One
|
2013
|
0.82
|
|
95
|
Characterization of inflammatory (lymphoepithelioma-like) hepatocellular carcinoma: a study of 8 cases.
|
Arch Pathol Lab Med
|
2014
|
0.82
|
|
96
|
Role of choline deficiency in the Fatty liver phenotype of mice fed a low protein, very low carbohydrate ketogenic diet.
|
PLoS One
|
2013
|
0.81
|
|
97
|
Validation of organ procurement and transplant network (OPTN)/united network for organ sharing (UNOS) criteria for imaging diagnosis of hepatocellular carcinoma.
|
Transplantation
|
2013
|
0.81
|
|
98
|
Radiologic and intraoperative detection of need for mesenteric vein resection in patients with adenocarcinoma of the head of the pancreas.
|
HPB (Oxford)
|
2011
|
0.81
|
|
99
|
Do you see what I see? The role of quality histopathology in scientific study.
|
Hepatology
|
2008
|
0.81
|
|
100
|
Histological features and severity of oxaliplatin-induced liver injury and clinical associations.
|
J Dig Dis
|
2014
|
0.80
|
|
101
|
Surgical assessment of significant steatosis in donor livers: the beginning of the end for frozen-section analysis?
|
Liver Transpl
|
2013
|
0.79
|
|
102
|
Estimation of fish and ω-3 fatty acid intake in pediatric nonalcoholic fatty liver disease.
|
J Pediatr Gastroenterol Nutr
|
2013
|
0.79
|
|
103
|
Heterogeneity of fibrosis patterns in non-alcoholic fatty liver disease supports the presence of multiple fibrogenic pathways.
|
Liver Int
|
2013
|
0.78
|
|
104
|
Hepatocellular progenitor cell tumor of the gallbladder: a case report and review of the literature.
|
Mod Pathol
|
2005
|
0.78
|
|
105
|
Chemoprevention of hepatocellular carcinoma: use of tamoxifen in an animal model of hepatocarcinogenesis.
|
J Lab Clin Med
|
2005
|
0.77
|
|
106
|
Parenchymal alterations in cirrhotic livers in patients with hepatopulmonary syndrome or portopulmonary hypertension.
|
Liver Transpl
|
2013
|
0.77
|
|
107
|
Expression of P-glycoprotein and C-MOAT in human hepatocellular carcinoma: detection by immunostaining.
|
Dig Dis Sci
|
2002
|
0.76
|
|
108
|
Coexistence of inflammatory hepatocellular adenomas with HNF1α-inactivated adenomas: is there an association?
|
Histopathology
|
2014
|
0.76
|
|
109
|
Divergent quasispecies evolution in de novo hepatitis C virus infection associated with bone marrow transplantation.
|
Biochem Biophys Res Commun
|
2011
|
0.75
|
|
110
|
Sustained resolution of fibrosing cholestatic hepatitis C despite viremic relapse after stopping pegylated interferon and ribavirin therapy.
|
Liver Transpl
|
2007
|
0.75
|
|
111
|
Plasminogen Activator Inhibitor-1 Predicts Quantity of Hepatic Steatosis Independent of Insulin Resistance and Body Weight.
|
J Pediatr Gastroenterol Nutr
|
2016
|
0.75
|
|
112
|
Polypoid lesions of the gallbladder: disease spectrum with pathologic correlation-erratum.
|
Radiographics
|
2015
|
0.75
|
|
113
|
Best cases from the AFIP: multiple gastric carcinoids.
|
Radiographics
|
2009
|
0.75
|
|
114
|
A 32-year-old man with hepatitis C who developed progressive liver failure after a bone marrow transplant.
|
Semin Liver Dis
|
2002
|
0.75
|
|
115
|
Histopathologic evaluation of liver biopsy for cirrhosis.
|
Adv Anat Pathol
|
2012
|
0.75
|
|
116
|
Familial adenomatous polyposis-associated ampullary adenoma: response to chemotherapy for concurrent metastatic adenocarcinoma.
|
Clin Gastroenterol Hepatol
|
2009
|
0.75
|
|
117
|
Evaluating liver disease in chronic hepatitis C--the role of the liver biopsy.
|
MedGenMed
|
2003
|
0.75
|
|
118
|
Polypoid Lesions of the Gallbladder: Disease Spectrum with Pathologic Correlation—Erratum.
|
Radiographics
|
2015
|
0.75
|